Our review aimed to understand the roles between Type I and Type III IFN in response to viral infections in the respiratory tract, and what IFN signatures may exist to predict severe disease or response to IFN-targeted therapies in viral respiratory infections. This evidence concerns the gene IFNA1 and viral infectious disease.